Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)

Clinical trial NCT04086485 · RECRUITING

Trial details

NCT number: NCT04086485
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gastroenteropancreatico Tumors Neuroendocrine Tumors Neuroendocrine Neoplasms

Start date: 2022-10-03
Primary completion: 2027-07-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.